v3.25.4
Equity Incentive Plan (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Dec. 18, 2025
Dec. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Shares subject to options (in shares)   947,775
Weighted average exercise price per share   $ 14.92
Weighted average grant date fair value (in dollars per share)   $ 1.50
Options to purchase shares    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expected future expense related to non-vested options outstanding, weighted average years   10 months 24 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross   240,000
Expected future expense related to non-vested options outstanding   $ 87
Restricted Stock Units    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Restricted stock and performance stock units, non-vested   627,520
Restricted stock and performance stock units, non-vested, weighted average grant date fair value (in dollars per share)   $ 13.78
Restricted stock units and performance stock units outstanding   1,393,268
Expected future compensation expense related to restricted stock and performance stock units outstanding   $ 6,961
Expected future expense related to non-vested options outstanding, weighted average years   3 years 1 month 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 215,200 371,700
Performance Shares    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Restricted stock and performance stock units, non-vested   675,100
Restricted stock and performance stock units, non-vested, weighted average grant date fair value (in dollars per share)   $ 13.81
Restricted stock units and performance stock units outstanding   675,100
Expected future compensation expense related to restricted stock and performance stock units outstanding   $ 8,531
Expected future expense related to non-vested options outstanding, weighted average years   3 years 9 months 18 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 322,800 478,800